rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Gossamer Bio, Inc.

GOSS · Nasdaq

Health CareBiotechnologyNot moving yet

GOSS stood above a rising 150-day average in 14 of the last 52 weekly readings, and has been out of that trend for the last 38 weeks. It is 52.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 38
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
163 (-12)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 14 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$48KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders163-12 on the quarter
New · exited29 · 42
Reported value$58.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
D. E. Shaw & Co., Inc.added · filed 14 Aug 202640,959,285$6.7M+40,569,854+10417.7%
683 Capital Management, LLCadded · filed 14 Aug 202639,198,868$6.5M+34,198,868+684.0%
DeepCurrents Investment Group LLCnew · filed 14 Aug 202637,665,073$6.0M+37,665,073
Context Capital Management, LLCnew · filed 23 Jul 202628,946,459$4.8M+28,946,459
Worth Venture Partners, LLCnew · filed 10 Aug 202625,017,881$4.1M+25,017,881
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 202615,629,993$2.6M+5,503,096+54.3%
WOLVERINE ASSET MANAGEMENT LLCnew · filed 10 Aug 202612,894,746$2.1M+12,894,746
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 202611,629,896$1.9M+10,412,028+854.9%
Kalehua Capital Management LLCadded · filed 14 Aug 202611,149,363$1.8M+3,677,523+49.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20269,416,023$1.6M+21,430+0.2%
31 Mar 2023 – 30 Jun 2026
87133179Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Gregory Austin Ciongoli Company insiderDirector · last 23 Sep 20260 · 0
John D. Quisel Company insiderDirector · last 23 Sep 20260 · 0
Russell J. Cox Company insiderDirector · last 23 Sep 20261 · 0
Sandra Milligan Company insiderDirector · last 23 Sep 20262 · 0
Skye Drynan Company insiderDirector · last 23 Sep 20260 · 0
Steven D. Nathan Company insiderDirector · last 23 Sep 20260 · 0
Thomas O. Daniel Company insiderDirector · last 23 Sep 20260 · 0
Bryan Giraudo Company insiderCOO/CFO · last 24 Aug 202610 · 3
Caryn Peterson Company insiderChief Development Officer · last 24 Aug 20260 · 5
Faheem Hasnain Company insiderPresident & CEO · last 24 Aug 20267 · 2
Robert Paul Smith Jr. Company insiderChief Commercial Officer · last 24 Aug 20261 · 0
Waage Christian Company insiderEVP, Tech Ops and Admin · last 24 Aug 20265 · 3

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-352%
Free cash flow marginFY 2025 · to 31 Dec 2025-354%
Return on capital employedFY 2025 · to 31 Dec 2025-157%
Share count trendFY 2025 · to 10 Mar 20260.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$37.7M
Free cash flowFY 2025 · to 31 Dec 2025−$171.3M

Analyst forecasts

No analyst forecasts yet.